Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 212

    1.

    Involvement of peripheral polymorphonuclear leukocytes in oxidative stress and inflammation in type 2 diabetic patients.

    Shurtz-Swirski R, Sela S, Herskovits AT, Shasha SM, Shapiro G, Nasser L, Kristal B.

    Diabetes Care. 2001 Jan;24(1):104-10.PMID: 11194213 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Participation of peripheral polymorphonuclear leukocytes in the oxidative stress and inflammation in patients with essential hypertension.

    Kristal B, Shurtz-Swirski R, Chezar J, Manaster J, Levy R, Shapiro G, Weissman I, Shasha SM, Sela S.

    Am J Hypertens. 1998 Aug;11(8 Pt 1):921-8.PMID: 9715783 [PubMed - indexed for MEDLINE]Related articles

    3.

    The involvement of peripheral polymorphonuclear leukocytes in the oxidative stress and inflammation among cigarette smokers.

    Sela S, Shurtz-Swirski R, Awad J, Shapiro G, Nasser L, Shasha SM, Kristal B.

    Isr Med Assoc J. 2002 Nov;4(11):1015-9.PMID: 12489494 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Advanced glycosylated end products-mediated activation of polymorphonuclear neutrophils in diabetes mellitus and associated oxidative stress.

    Gupta A, Tripathi AK, Tripathi RL, Madhu SV, Banerjee BD.

    Indian J Biochem Biophys. 2007 Oct;44(5):373-8.PMID: 18341213 [PubMed - indexed for MEDLINE]Related articles

    5.

    In vitro effect of zinc on superoxide anion production by polymorphonuclear leukocytes of diabetic patients.

    Gavella M, Lipovac V, Car A.

    Acta Diabetol. 2000;37(3):135-7.PMID: 11277314 [PubMed - indexed for MEDLINE]Related articles

    6.

    Intensification of oxidative stress and inflammation in type 2 diabetes despite antihyperglycemic treatment.

    Farah R, Shurtz-Swirski R, Lapin O.

    Cardiovasc Diabetol. 2008 Jun 22;7:20.PMID: 18570678 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Primed peripheral polymorphonuclear leukocyte: a culprit underlying chronic low-grade inflammation and systemic oxidative stress in chronic kidney disease.

    Sela S, Shurtz-Swirski R, Cohen-Mazor M, Mazor R, Chezar J, Shapiro G, Hassan K, Shkolnik G, Geron R, Kristal B.

    J Am Soc Nephrol. 2005 Aug;16(8):2431-8. Epub 2005 Jun 29. Erratum in: J Am Soc Nephrol. 2005 Sep;16(9):2814. PMID: 15987755 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Primed polymorphonuclear leukocytes constitute a possible link between inflammation and oxidative stress in hyperlipidemic patients.

    Mazor R, Shurtz-Swirski R, Farah R, Kristal B, Shapiro G, Dorlechter F, Cohen-Mazor M, Meilin E, Tamara S, Sela S.

    Atherosclerosis. 2008 Apr;197(2):937-43. Epub 2007 Sep 17.PMID: 17869258 [PubMed - indexed for MEDLINE]Related articles

    9.

    Production of superoxide anion by polymorphonuclear leukocytes from diabetic patients with or without diabetic retinopathy.

    Abu el-Asrar AM, Soliman RT, al-Amro SA, al-Shammary FJ.

    Doc Ophthalmol. 1995-1996;91(3):243-54.PMID: 8886588 [PubMed - indexed for MEDLINE]Related articles

    10.

    Nicotinamide effects oxidative burst activity of neutrophils in patients with poorly controlled type 2 diabetes mellitus.

    Osar Z, Samanci T, Demirel GY, Damci T, Ilkova H.

    Exp Diabesity Res. 2004 Apr-Jun;5(2):155-62.PMID: 15203886 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Increased polymorphonuclear leukocyte respiratory burst function in type 2 diabetes.

    Hand WL, Hand DL, Vasquez Y.

    Diabetes Res Clin Pract. 2007 Apr;76(1):44-50. Epub 2006 Sep 7.PMID: 16959366 [PubMed - indexed for MEDLINE]Related articles

    12.

    Chemiluminescence and superoxide anion production by leukocytes from diabetic patients.

    Shah SV, Wallin JD, Eilen SD.

    J Clin Endocrinol Metab. 1983 Aug;57(2):402-9.PMID: 6306042 [PubMed - indexed for MEDLINE]Related articles

    13.

    Oxidative stress during hemodialysis: effect of heparin.

    Sela S, Shurtz-Swirski R, Shapiro G, Nasser L, Hamzi M, Shasha SM, Kristal B.

    Kidney Int Suppl. 2001 Feb;78:S159-63.PMID: 11169003 [PubMed - indexed for MEDLINE]Related articles

    14.

    Interaction between erythropoietin and peripheral polymorphonuclear leukocytes in hemodialysis patients.

    Kristal B, Shurtz-Swirski R, Shasha SM, Manaster J, Shapiro G, Furmanov M, Hassan K, Weissman I, Sela S.

    Nephron. 1999;81(4):406-13.PMID: 10095176 [PubMed - indexed for MEDLINE]Related articles

    15.

    Effect of tolrestat, an aldose reductase inhibitor, on neutrophil respiratory burst activity in diabetic patients.

    Ihm SH, Yoo HJ, Park SW, Park CJ.

    Metabolism. 1997 Jun;46(6):634-8.PMID: 9186297 [PubMed - indexed for MEDLINE]Related articles

    16.

    Hyperglycemia induced oxidative stress in type-1 and type-2 diabetic patients with and without nephropathy.

    Dave GS, Kalia K.

    Cell Mol Biol (Noisy-le-grand). 2007 May 30;53(5):68-78.PMID: 17543235 [PubMed - indexed for MEDLINE]Related articles

    17.

    Cilostazol reduces inflammatory burden and oxidative stress in hypertensive type 2 diabetes mellitus patients.

    Agrawal NK, Maiti R, Dash D, Pandey BL.

    Pharmacol Res. 2007 Aug;56(2):118-23. Epub 2007 May 3.PMID: 17548203 [PubMed - indexed for MEDLINE]Related articles

    18.

    Evidence of ex vivo and in vitro impaired neutrophil oxidative burst and phagocytic capacity in type 1 diabetes mellitus.

    Marhoffer W, Stein M, Schleinkofer L, Federlin K.

    Diabetes Res Clin Pract. 1993 Mar;19(3):183-8.PMID: 8319516 [PubMed - indexed for MEDLINE]Related articles

    19.

    Oxidative stress, inflammation and neutrophil superoxide release in patients with Crohn's disease: distinction between active and non-active disease.

    Maor I, Rainis T, Lanir A, Lavy A.

    Dig Dis Sci. 2008 Aug;53(8):2208-14. Epub 2008 Feb 6.PMID: 18253831 [PubMed - indexed for MEDLINE]Related articles

    20.

    Interaction between erythropoietin and peripheral polymorphonuclear leukocytes in continuous ambulatory dialysis patients.

    Shurtz-Swirski R, Kristal B, Shasha SM, Shapiro G, Geron R, Sela S.

    Nephron. 2002 Aug;91(4):759-61.PMID: 12138286 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data